Aus dem Tumorboard – Begrenzt metastasiertes Mammakarzinom einer 90-jährigen Patientin

• Literatur

• 1 Petrakis IE, Paraskakis S. Breast cancer in the elderly. Archives of gerontology and geriatrics 2010; 50: 179-184
• 2 Hancke K, Denkinger MD, König J, Kurzeder C, Wöckel A, Herr D, Kreienberg R. Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. Annals of oncology 2010; 21: 748-753
• 3 Dellapasqua S, Colleoni M, Castiglione M et al. New criteria for selecting elderly patients for breast cancer adjuvant treatment studies. The oncologist 2007; 12: 952-959
• 4 Cardoso F, Costa A, Norton L et al. 1st International consensus guidelines for advanced breast cancer (ABC 1). The Breast 2012; 21: 242-252
• 5 Charlson M, Szatrowski TP, Peterson J et al. Validation of a combined comorbidity index. Journal of clinical epidemiology 1994; 47: 1245-1251
• 6 Cardoso F, Bischoff J, Brain E et al. A review of the treatment of endocrine responsive metastatic breast cancer in postmenopausal women. Cancer Treat Rev 2012; 39: 457-65
• 7 Sainsbury R. The development of endocrine therapy for women with breast cancer. Cancer Treat Rev 2012; 39: 507-517
• 8 Hortobagyi GN, Piccart M, Rugo H, Burris H, Campone M, Noguchi G M, Baselga J. Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial. Cancer Res 2011; 71: 105-106